Reinventing healthcare
Improving lives
About
NETRI
NETRI
NETRI develops disruptive technologies to improve healthcare pathway for patients suffering from neurological troubles.
Our
Technology
Technology
NETRI uses the organ-on-a-chip approach to develop treatments for neurological disorders.
We focuse on our internal R&D to understand how neurodegenerative diseases, treatments and chemicals affect the human brain. We investigate ex vivo complex neuronal architectures that model human brain circuits.
Once validated, neurofluidic chips are directly accessible to academia, pharmaceutical industry or biotechnological companies for their research.
We believe in ideas that can be turned into proof of concept and real products.
Our
BRANDS
BRANDS
NEUROFLUIDICS™
High throughput microfluidic devices for
in vitro drug discovery in neuroscience
NEUROSCOPE™ LABS
Customized Neurofluidics devices targeted for your application
Our
CLIENTS
& PARTNERS
CLIENTS
& PARTNERS
NETRI establishes strategic business partnerships, as well as academic-industrial collaborations, with public and private entities (in France and worldwide). These collaborations lead to the development of our unique scientific and industrial approach, and to major IP and publications.
STAY INFORMED !
Subscribe to our Newsletter and be the first to know about the lastest published papers using neurofluidics chips,the upcoming conferences in the field, our new scientific achievements.
Neuro Engineering Technologies Research Institute
NETRI SAS, Bâtiment DomiLyon, 321 avenue Jean Jaurès, 69007 Lyon, France
SAS au capital de 1 331 € immatriculée au R.C.S de Lyon sous le n° 840 248 744
contact@netri.fr – +33487628118
SAS au capital de 1 331 € immatriculée au R.C.S de Lyon sous le n° 840 248 744
contact@netri.fr – +33487628118
Directeur de la publication – Thibault Honegger
Site hébergé par Online, 8 rue de la Ville l’Evêque, 75008 Paris, +33 (0)1 84 13 00 00
Site hébergé par Online, 8 rue de la Ville l’Evêque, 75008 Paris, +33 (0)1 84 13 00 00